Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 March 2023 | Story Nonsindiso Qwabe | Photo Stephen Collett
Prof Francis Petersen_ UFS Official Opening 2023
Prof Francis Petersen outlined the strategic intent of Vision 130 during his official welcoming address.

The trajectory to 2034, when the university turns 130, is not a dream, but an exciting journey that we are working towards achieving. Painting a picture of the university of the future, UFS Rector and Vice-Chancellor, Prof Francis Petersen, welcomed staff in his official opening speech on the Bloemfontein Campus on Friday 17 February 2023.

2023 marks the starting point of Vision 130, a vision with bold ambitions that will lead us to the renewal, re-imagining, and repositioning of the UFS in 2034, Prof Petersen said.  “We are building on our strengths, achievements, and learnings of our past and, in particular, the past five years. The vision is driven by excellence, and we won’t compromise excellence. It is about excellence, but it is also about visibility as an institution, and it is about impact.”

What does the UFS look like in 2034?

Prof Petersen said ours will be a university of choice for exceptional students, exceptional academics, and exceptional support staff. We will be recognised and acknowledged by peers and society as a top-tier university in South Africa, specifically among the top five universities in South Africa and the top 600 globally.

“Remember, I said we have built on the past, specifically the past five years, to give us a foundation. Still, we need to use that foundation to be able to deliver those specific goals or activities or deliverables that we want to achieve. We will have to start now if we want to achieve this in 2034.”

The Rector outlined four goals towards achieving these commitments:

• Improving academic excellence, improving our reputation, and improving our impact.

• Promoting an environment of agility, flexibility, and responsiveness.

• Advancing a transformational institutional culture that demonstrates the values of the University of the Free State – a place where ideas are discussed, contested, improved, and implemented in a culture of civil, robust engagement.

• Promoting stewardship and the prioritisation of institutional resources for strategic intent, which include our people, our staff, and our students.

Understand how your space is connected to Vision 130

“This is about creating a culture of delivery and empowering everyone within the University of the Free State and the UFS community to contribute to the realisation of Vision 130. This is what I am asking of you within your own sphere of operation. I am asking for a renewed commitment from you to own that space that you operate in. To understand how your space is connected to Vision 130 and to share what I would call an unrelenting ambition to deliver on this vision.”

Watch recording of the 2023 Official Opening below:


News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept